(Q33770093)

29 July 2017

title

A randomized controlled study comparing once-weekly to every-2-week and every-4-week dosing of epoetin alfa in CKD patients with anemia (English)

1 reference

29 July 2017

Pablo E Pergola

1

1 reference

29 July 2017

Gary Gartenberg

2

1 reference

29 July 2017

Min Fu

3

1 reference

29 July 2017

Steven Sun

4

1 reference

29 July 2017

Marsha Wolfson

5

1 reference

29 July 2017

Peter Bowers

6

1 reference

29 July 2017

publication date

25 February 2010

1 reference

Clinical Journal of the American Society of Nephrology

29 July 2017

published in

1 reference

29 July 2017

volume

5

1 reference

29 July 2017

issue

4

1 reference

29 July 2017

page(s)

598-606

1 reference

A randomized controlled study of weekly and biweekly dosing of epoetin alfa in CKD Patients with anemia

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2849701

In the clinic. Chronic kidney disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2849701

Pharmacokinetic and pharmacodynamic profiles of extended dosing of epoetin alfa in anemic patients who have chronic kidney disease and are not on dialysis

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2849701

A randomized study of extended dosing regimens for initiation of epoetin alfa treatment for anemia of chronic kidney disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2849701

C.E.R.A. corrects anemia in patients with chronic kidney disease not on dialysis: results of a randomized clinical trial.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2849701

Extended epoetin alfa dosing in chronic kidney disease patients: a retrospective review

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2849701

Novel erythropoiesis stimulating protein for managing the anemia of chronic kidney disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2849701

Predictors of hospitalization and death among pre-dialysis patients: a retrospective cohort study

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2849701

Normalizing hematocrit in dialysis patients improves brain function

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2849701

Quality of life in predialytic uremic patients.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2849701

Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2849701

Epoetin alfa once every 2 weeks is effective for initiation of treatment of anemia of chronic kidney disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2849701

Extended epoetin alfa dosing as maintenance treatment for the anemia of chronic kidney disease: the PROMPT study

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2849701

The prevalence of anemia in patients with chronic kidney disease

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2849701

Once-weekly epoetin alfa for treating the anemia of chronic kidney disease

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2849701

Novel erythropoiesis stimulating protein for treatment of anemia in chronic renal insufficiency.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2849701

The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2849701

IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: update 2000

30 October 2018

1 reference

12 December 2020

Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994)

1 reference

12 December 2020

Novel erythropoiesis-stimulating protein in the management of the anemia of chronic renal failure

1 reference

12 December 2020

Subcutaneous epoetin-alpha every one, two, and three weeks in renal anemia

1 reference

12 December 2020

The safety and the efficacy of maintenance therapy of recombinant human erythropoietin in patients with renal insufficiency

1 reference

12 December 2020

Early intervention with recombinant human erythropoietin therapy

1 reference

12 December 2020

Haemoglobin at time of referral prior to dialysis predicts survival: an association of haemoglobin with long-term outcomes

1 reference

12 December 2020

Identifiers

DOI

10.2215/CJN.06770909

1 reference

29 July 2017

1 reference

29 July 2017

1 reference